Suggested Treatment Algorithms for the Management of ... | GrepMed
JCM | Free Full-Text | Temporal Artery Vascular Diseases
Characteristics of Giant Cell Arteritis Flares After Successful Treatment with Tocilizumab: Results from the Long-Term Extension of a Randomized Controlled Phase 3 Trial - ACR Meeting Abstracts
2021 ACR/VF GCA/TAK Guidelines - Vasculitis Foundation
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica | Nature Reviews Rheumatology
Corticosteroids reduce vascular ultrasound sensitivity even with short duration: results from Coventry Multi-Disciplinary Fast Track Pathway for management of Giant Cell Arteritis | medRxiv
Article: Extracranial giant cell arteritis: A narrative review (full text) - June 2016 - NJM
Flowchart for giant cell arteritis (GCA) patients treated by dapsone... | Download Scientific Diagram
Current advancements in the management of giant cell arteritis | Aging Health
Giant cell arteritis: Current treatment and management
Cureus | Giant Cell Arteritis and Cardiac Comorbidity | Article
Vascular Disease Patient Information Page: Giant cell (temporal) arteritis - Samip Sheth, Alexandra Solomon, Brendan Antiochos, Natalie Evans, Elizabeth V Ratchford, 2022
Giant cell arteritis (GCA) | Causes, symptoms, treatments
The Diagnosis and Treatment of Giant Cell Arteritis (24.05.2013)
2021 ACR/VF GCA/TAK Guidelines - Vasculitis Foundation
Frontiers | The Treatment of Giant Cell Arteritis in Different Clinical Settings
Giant Cell Arteritis: An Update on Diagnosis and Management
2018 Update of the EULAR recommendations for the management of large vessel vasculitis | Annals of the Rheumatic Diseases
Non-Covid clinical crises: Temporal (giant cell) arteritis - Pulse Today
Giant cell arteritis
Vascular Disease Patient Information Page: Giant cell (temporal) arteritis - Samip Sheth, Alexandra Solomon, Brendan Antiochos, Natalie Evans, Elizabeth V Ratchford, 2022
Trial of Tocilizumab in Giant-Cell Arteritis | NEJM
